How Depression Is Diagnosed: The Depression Test, Screening Questionnaires, and When a Clinician Steps In
There is no blood test, brain scan, wearable, or online quiz that diagnoses depression — here is how a clinician actually does it, and what the PHQ-9, DSM-5 criteria, and blood tests are (and are not) for.

Short Answer
There is no single lab test, scan, wearable score, or online quiz that can diagnose depression by itself. Depression is diagnosed through a clinical assessment: a qualified clinician asks what you've been feeling, how long it has been going on, how it affects sleep, appetite, energy, concentration, work, relationships, and safety, and then checks that whole picture against diagnostic criteria such as the DSM-5 or ICD-11 (StatPearls / NCBI Bookshelf).
A "depression test" — whether you take it online, in an app, or on paper — is a screening questionnaire, not a diagnosis. Tools like the PHQ-2 and PHQ-9 are useful because they turn vague, heavy, hard-to-explain symptoms into a structured score a clinician can act on. A higher score can mean, "please look closer," but it still needs a real conversation: what changed, what else is happening in your body and life, whether anxiety, grief, trauma, substances, medications, bipolar disorder, thyroid disease, anemia, vitamin deficiency, sleep problems, or another condition could be part of the picture (PubMed).
That is why clinicians may also order blood tests. Not because blood can "prove" depression, but because the body can mimic mood symptoms. Low thyroid function, anemia, vitamin B12 or folate problems, and other medical issues can show up as exhaustion, brain fog, low motivation, sleep changes, or feeling slowed down. Checking labs helps rule out treatable physical causes before your clinician labels the problem as depression alone (Mayo Clinic).
A wearable cannot diagnose depression either. What it can do is add context: resting heart rate, HRV, sleep timing, sleep regularity, activity, and circadian patterns can show how your nervous system and routines are behaving while your mood is changing. Those signals may support screening or monitoring, but they are not a substitute for a clinician's assessment, especially when safety, suicide risk, medication decisions, or another medical condition may be involved (PubMed).
How depression is assessed — at a glance
A screening questionnaire, such as the PHQ-9 or the shorter PHQ-2, is usually the first filter. You answer questions about mood, sleep, appetite, energy, focus, stress, and how much symptoms interfere with life. A score can flag that you may need a fuller assessment, and repeating the same questionnaire over time can help track whether symptoms are getting better or worse. But a questionnaire is not the same as a diagnosis. It cannot see the whole picture: grief, trauma, bipolar symptoms, substance use, medication effects, thyroid disease, anemia, sleep problems, or immediate safety risk all need human clinical judgment (MedlinePlus).
A clinical assessment is where diagnosis actually happens. A clinician asks about your symptoms, thoughts, behavior patterns, duration, severity, daily functioning, medical history, medicines, alcohol or drug use, and personal or family mental health history. They may use DSM-5 criteria and may ask you to complete a questionnaire as one part of the conversation. That is why an app or online quiz can support reflection, but it cannot replace a clinician: depression diagnosis depends on context, impairment, differential diagnosis, and safety assessment, not a score alone (Mayo Clinic).
Blood tests are not depression tests. They are used to check whether something in the body could be causing or worsening depression-like symptoms — for example anemia, thyroid problems, vitamin deficiencies, inflammation, infection, medication effects, or other medical conditions. This matters because fatigue, low motivation, brain fog, sleep changes, and low mood can come from more than one system at once. There is no lab test or blood marker that can confirm depression by itself (MedlinePlus).
Wearable and HRV data can add useful context, especially when you bring trends to a clinician: resting heart rate, HRV, sleep timing, sleep regularity, activity, recovery load, and changes from your own baseline may help explain what your body has been carrying. Research on wearables and digital biomarkers is promising, but still limited; studies suggest these signals may help identify risk patterns or support screening research, not diagnose depression on their own. Your watch can show strain, sleep disruption, or physiological change — it cannot decide whether you have depression or rule out suicide risk (PubMed).
There is no blood test for depression — it's a clinical diagnosis
Depression is diagnosed by a clinician, not by a machine, an app, a brain scan, or a lab result. There isn't a blood test that can "show" depression the way a glucose test can show high blood sugar. Blood work may still be useful — for example, to look for thyroid problems, vitamin deficiencies, medication effects, substance use, or other medical issues that can feel like depression — but those tests help rule things in or out around the diagnosis. They do not diagnose depression on their own (StatPearls / NCBI Bookshelf).
The standard assessment is a conversation: "the standard assessment of mental health typically involves clinical interviews conducted by highly trained clinicians" (Sikström et al., *Scientific Reports*, 2025). During that assessment, a clinician asks about mood, loss of interest, sleep, energy, appetite, concentration, guilt or worthlessness, slowed or agitated movement, and thoughts of death or self-harm. They also ask how long this has been going on, whether it is a change from your usual self, how much it interferes with work, school, relationships, or basic daily care, and whether another condition, medication, substance, grief reaction, or bipolar disorder could better explain what is happening.
That "how long" and "how much it interferes" part matters. In DSM-5 framing, a major depressive episode involves five or more symptoms during the same 2-week period, with at least one being depressed mood or loss of interest or pleasure, and the symptoms must cause clinically significant distress or impairment. ICD-11 uses a similar clinical frame for depressive episodes: symptoms such as depressed mood or loss of pleasure/interest occur most of the day, nearly every day, for at least 2 weeks, with significant distress or impairment in functioning (DSM-5 Major Depressive Episode criteria, NCBI Bookshelf).
That is why an online "depression test" cannot, by itself, tell you whether you have depression. A questionnaire like the PHQ-9 can organize what you are feeling, show symptom severity, and make it easier to start a clear conversation with a clinician. That is genuinely useful. But a score is not the diagnosis. The diagnosis is a clinical judgment made by a qualified person who can hear the story behind the score, check safety, consider context, and rule out other causes (Cleveland Clinic).
What a "depression test" actually is — PHQ-9 and PHQ-2
When people search for a depression test, what they usually find is not a lab test or a brain scan. It is a questionnaire: a structured way to ask about symptoms, put them into a score, and decide whether the next step should be a real clinical conversation. The best-known example is the PHQ-9 — the Patient Health Questionnaire with 9 symptom items. Its shorter version, the PHQ-2, uses 2 core questions and is often used as a quick first screen before a fuller questionnaire. These tools can help notice depression symptoms that might otherwise stay hidden, but they are still screening tools, not a diagnosis by themselves (NIH).
The PHQ-9 gives you a number, and that number is useful because it turns a vague feeling — "I'm not okay" — into something easier to discuss. Researchers commonly group PHQ-9 scores into severity bands. In one large study, "Symptom severity was categorised into three levels: none (0-4 points), mild (5-9 points) or moderate to severe (10-24 points)" (Hong et al., *BJPsych Open*, 2025). Another population study used a commonly cited cutoff and defined depression "with a score ≥ 10 defining clinically significant depression" (Qian et al., *International Journal of Endocrinology*, 2026).
But the important part is what the score does not do. A cutoff can flag probability; it cannot look at your full life, your medical history, medication effects, thyroid problems, grief, trauma, substance use, bipolar symptoms, sleep loss, or whether symptoms are causing impairment in the way diagnostic criteria require. That is why a high PHQ-9 score is a reason to talk to a clinician, not a verdict from an app. Clinical diagnosis still needs clinical assessment and judgment (PMC).
Crucially, the PHQ-9's ninth item asks directly about thoughts of death or self-harm. If that item is anything other than "not at all," it should prompt a real conversation with a clinician or crisis line — not be brushed off. If you are having thoughts of suicide, call or text 988 in the US (or 111 / Samaritans 116 123 in the UK) right now. The reason this matters is simple: item 9 is not just "another symptom question." Studies link responses to this item with higher later risk of suicide attempt or suicide death, so any answer above "not at all" deserves human follow-up, not automated reassurance (PubMed).
Screening is not the same as diagnosis — and the guidelines say so
It's tempting to treat a screening score as an answer, especially when the number looks precise. But major guideline bodies draw a hard line between a questionnaire and a diagnosis. A 2025 Canadian Task Force on Preventive Health Care update reviewed "instrument-based screening (i.e., using a screening tool) for depression" and came to a deliberately cautious conclusion: it recommended "against screening all adults aged 18 years and older for depression using questionnaires" on its own as a population program, because routine questionnaire screening for everyone showed little to no measurable benefit for depression symptoms or health-related quality of life in the evidence the task force reviewed (Lang et al., *CMAJ*, 2025).
That does not mean questionnaires are useless. It means the score is a doorway, not the room. A PHQ-9 or similar tool can help you name what has been happening in your mood, sleep, appetite, energy, concentration, and sense of hope. It can make a vague "I'm not okay" easier to bring into a medical visit. But the task force is clear that its population-screening recommendation is not aimed at people already being assessed, already diagnosed, seeking mental health care, or clinically suspected to have depression. In its wording, the recommendation "does not apply to adults with a personal history, current diagnosis" of depression or those already flagged as at risk; for them, tracking symptoms is part of care, not the same thing as mass screening (Lang et al., *CMAJ*, 2025).
Other guidance points in the same direction from a different angle. The US Preventive Services Task Force recommends screening adults for depression in primary care, including pregnant and postpartum people and older adults, while its evidence review frames screening as useful when it connects to accurate diagnosis, treatment, and follow-up — not when a questionnaire is left to stand alone (USPSTF, *JAMA*, 2023). The NHS describes diagnosis as a clinical conversation: a GP asks about your general health, how your symptoms affect daily life, medical history, previous mental health problems, current stressors, and thoughts of suicide or self-harm; they may also examine you or order urine or blood tests to rule out other conditions with similar symptoms, such as an underactive thyroid. A questionnaire may be used to assess symptoms, but it is one piece of the assessment, not the diagnosis itself (NHS).
The guidelines also make the stakes explicit. Depression, the same task force notes, "is associated with impaired functioning in social and work settings; and can be associated with thoughts of suicide" (Lang et al., *CMAJ*, 2025). That is exactly why a positive screen should lead to a real conversation, not a self-diagnosis — and why any thought of suicide is a reason to reach out for help immediately: 988 in the US; 111 / Samaritans 116 123 in the UK; 911 or emergency services if there is immediate danger.
Blood tests and ruling out physical causes
People often search for blood tests for fatigue and depression, hoping for a lab test that confirms what is happening in their mind. There isn't one. Depression is diagnosed through a clinical assessment: your symptoms, their duration, how they affect your life, your medical history, a mental health evaluation, and diagnostic criteria. Blood or urine tests can still matter — not because they "detect depression," but because they help a clinician check whether something in the body could be producing depression-like symptoms, such as low energy, slowed thinking, poor concentration, sleep disruption, or low mood. The NHS is explicit that there are no physical tests for depression, but a GP may run blood or urine tests to rule out conditions with similar symptoms, including an underactive thyroid. Mayo Clinic describes lab testing in the same way: a clinician may order a complete blood count or thyroid testing as part of the broader diagnostic work-up (NHS).
The exact tests depend on your symptoms, health history, medications, menstrual bleeding, diet, age, pregnancy status, and risk factors — there is no universal "depression blood panel." Common checks include thyroid function, often starting with TSH, because hypothyroidism can feel like depression from the inside: heavy fatigue, slowed body systems, low drive, and foggy thinking. Clinicians may also check a complete blood count and iron studies, including ferritin, because iron deficiency anemia can leave you exhausted, weak, breathless, dizzy, and unable to think clearly. Vitamin testing may be considered when the story fits: B12 or folate deficiency can cause anemia and tiredness, and low B12 has also been linked with mood symptoms; vitamin D testing is a blood test, but it is usually targeted rather than automatic for everyone (Mayo Clinic).
If one of these results is abnormal, treating the underlying problem may ease some or all of the fatigue, brain fog, or low mood. If the tests are normal, that does not mean your symptoms are "not real." It means the clinician has fewer signs pointing to a physical mimic and can focus more closely on a mood assessment, your safety, your functioning, and what kind of support or treatment fits. Either way, the blood test is an exclusion tool. It helps answer "Could something else be driving this?" — not "Do I have depression?"
You may also see headlines about a "blood test for depression." Treat those as research, not routine clinical care. Scientists are studying possible biomarkers — inflammatory signals, hormones, genetic and epigenetic markers, metabolites, microRNAs, mitochondrial DNA, and machine-learning combinations — because the biology of depression is real and worth understanding. But that is different from having a validated clinic test that can diagnose you. Reviews continue to describe depression biomarkers as promising but not ready to replace clinical diagnosis: one review found no approved reliable molecular or genetic biomarker for clinical diagnosis, and metabolomics research has not yet produced enough evidence to change current diagnostic practice (PubMed).
Depression alongside other diagnoses
Two long-tail searches show up here: depression after an ADHD diagnosis and depression after a diabetes diagnosis. Both point to a real clinical pattern: depression can sit alongside a neurodevelopmental or chronic condition, and the overlap can make it harder to notice what is new. ADHD can co-occur with depression, and NIMH notes that co-occurring conditions can make ADHD harder to diagnose and treat. In daily life, that can look like a messy blur: trouble concentrating may be read as "just ADHD," while fatigue, low drive, or loss of interest may be missed as depressive symptoms unless someone asks about mood directly (NIMH).
Diabetes has a similar mind-body loop. CDC describes depression as more common in people with diabetes than in people without diabetes, and also notes that untreated mental health problems can make diabetes harder to manage — while diabetes problems can worsen mental health. That does not mean diabetes "causes" depression in a simple one-way line. It means the load on your body and your day-to-day self-care can feed back into mood, sleep, energy, food choices, glucose management, and the feeling that everything takes too much effort (CDC).
This is one reason clinicians assess depression inside the full health picture, not as a standalone score. If you were recently diagnosed with ADHD, diabetes, or another chronic condition and your mood has dropped, say that plainly: "Since this diagnosis, I've felt lower, more tired, less interested, or less able to function." It is common enough to be taken seriously, and it is treatable — but it should be assessed directly rather than written off as stress, personality, willpower, or "just part of" the other diagnosis (CDC).
Where wearables and Welltory fit — and where they don't
Let's be blunt about the anti-hype question first: a wearable or an app cannot diagnose depression, and Welltory is not a depression screener. No consumer device measures depression, and a single HRV or heart-rate number cannot tell anyone whether they are depressed. Depression is diagnosed through a clinical assessment: a provider looks at your symptoms, how long they have lasted, how they affect your life, and whether another medical condition, medicine, substance use, or mental health condition could be part of the picture. Screening questionnaires can help start that conversation, but they do not replace it (MedlinePlus).
Research is exploring whether physiological signals correlate with depressive symptoms, and the honest read is still: modestly, at best. In a 2026 study, "Heart rate variability (HRV) has emerged as a potential physiological marker of depression," and a contactless model built on HRV features "achieved its best discrimination of AUROC 0.64" — better than chance, but far from diagnostic. The authors are careful: "Although predictive performance was modest, this non-invasive approach shows promise for accessible, large-scale depression screening" (Jhon et al., *Translational Psychiatry*, 2026). In other words, HRV might one day help screen, not diagnose — and even that is early research. A 2026 systematic review also describes HRV's prospective value for future depressive symptoms as uncertain, which is exactly why this belongs in the "possible signal" bucket, not the "answer" bucket (PubMed).
So what is a wearable actually good for here? Context. Depression can change the body before you have clean words for it: sleep gets shorter, longer, lighter, or broken; energy drops; activity shrinks; mornings feel harder; your body may look more stressed even when you are doing less. Welltory tracks patterns such as sleep, activity, resting heart rate, and HRV trends. Those patterns do not diagnose anything, but they can help you describe what's been happening in your body to a clinician: "my sleep has been fragmented for weeks," "my activity has dropped off," "my resting heart rate has crept up," "my recovery scores changed around the same time my mood did." That kind of concrete, longitudinal picture can make a clinical conversation more useful. Welltory carries sleep, activity, and HRV patterns to the doctor — it does not stand in for the doctor (Cleveland Clinic).
Depression is also frequently missed: as one screening study notes, it "is a prevalent mental health condition that frequently remains undiagnosed" (Jhon et al., *Translational Psychiatry*, 2026). If your own data shows a persistent change, treat that as a prompt to book an assessment — not as a diagnosis you can make yourself. The useful question is not "Does my HRV prove I'm depressed?" It's "Has something changed enough that I should talk to a qualified person?" If the answer is yes, bring the pattern, bring the dates, bring the symptoms, and let the clinician do the diagnosing.
When to seek help now
Some symptoms are not a "wait and see." If you are thinking about suicide, harming yourself, or you feel unable to stay safe, get help immediately. You do not have to prove that it is "serious enough." A crisis can mean you are in danger right now, or that the thoughts are getting too loud to handle alone.
US: Call or text 988 (Suicide and Crisis Lifeline), 24/7. If you or someone else is in immediate danger, call 911 or go to the nearest emergency room (SAMHSA).
UK: Call 111, or the Samaritans on 116 123 (free, 24/7) (NHS).
If in doubt, reach out. It is okay to call because you are scared, because you might act on a thought, because you have harmed yourself, or because you are not sure you can get through the next hour safely.
How we made it
Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team.


Discounts for blog readers: up to 36% off
See what affects your energy, stress, sleep, and daily state with Welltory
This article is for educational purposes only and does not replace medical diagnosis. There is no blood test, brain scan, or wearable that can diagnose depression on its own. An online depression test or a questionnaire like the PHQ-9 is a screening tool, not a diagnosis — only a qualified clinician can diagnose depression. If you are thinking about suicide or self-harm, help is available right now. In the US, call or text 988 (the Suicide and Crisis Lifeline), 24/7. If you or someone else is in immediate danger, call 911 or go to the nearest emergency room. In the UK, call 111 or the Samaritans on 116 123.
Was this helpful?
Ask AI for a summary of page
Written by Jane Smorodnikova
The founder and CEO of Welltory. A recognized tech leader with two Master's degrees and experience at MIT, she has scaled Welltory to over 17 million users.
Written by Kseniia Iaroslavtseva
Reviewed by Anna Elitzur
With her medical degree, Anna reviews Welltory's health content for medical accuracy and alignment with current clinical guidelines and research.
References
- Sikström S, Boehme RA, Mirström M, et al. https://pmc.ncbi.nlm.nih.gov/articles/PMC12572119/
- Hong W, Yang Y, Xing Z. https://pubmed.ncbi.nlm.nih.gov/41078062/
- Qian H, Song S, Zhang Z, Yuan Y, Wu D. https://pmc.ncbi.nlm.nih.gov/articles/PMC12891436/
- Lang E, Gray C, LeBlanc JC, Colquhoun H, Traversy G; Canadian Task Force on Preventive Health Care. https://pubmed.ncbi.nlm.nih.gov/41115725/
- Jhon M, Kim JW, Lee K, et al. https://pmc.ncbi.nlm.nih.gov/articles/PMC12858836/
- National Institute of Mental Health. https://www.nimh.nih.gov/health/publications/depression
- NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK498652/table/depress-diab.T.dsm5__major_depressive_ep/?report=objectonly
- US Preventive Services Task Force. https://pubmed.ncbi.nlm.nih.gov/37338872/
- Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/depression/diagnosis-treatment/drc-20356013
- NHS. https://www.nhs.uk/mental-health/conditions/depression-in-adults/diagnosis/
- Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/mental-health/988


-2.jpg)
